A groundbreaking study reveals that a single dose of psilocybin, the active compound in magic mushrooms, can provide ...

A groundbreaking study published in the journal Cancer has found that a single dose of psilocybin, when combined with ...

Half a decade after receiving a psychedelic treatment for depression, two-thirds of patients in a new study remained in ...

This is huge for people with depression who've tried everything else and are still suffering,' says Deputy Prime Minister ...

New research shows a single psilocybin session with therapy can reduce depression in cancer patients for up to two years.

Scientists have dug up more evidence of the benefits of so-called "magic" mushrooms with the publication of clinical trial ...

DENVER—Psilocybin, the main psychoactive ingredient in magic mushrooms, can alleviate depression for at least five years after a single dose, a new study finds.

Psilocybin, the active ingredient in magic mushrooms, might just revolutionize how depression and anxiety are treated in ...

The psilocybin found in "magic mushrooms" might be key to quelling depression among people battling cancer, a new study found ...

New Zealand has approved the restricted medicinal use of psilocybin, a hallucinogen found in “magic mushrooms” for patients ...

The Federal Court of Appeal is ordering Canada's Health Minister to rethink a 2022 refusal to grant exemptions to 96 ...

A new study from the American Cancer Society’s medical journal found that psilocybin — the active ingredient in “magic ...